WallStreetZenWallStreetZen

NASDAQ: NPCE
Neuropace Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

NPCE past revenue growth

How has NPCE's revenue growth performed historically?
Company
43.72%
Industry
9.32%
Market
17.91%
NPCE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NPCE's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NPCE's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NPCE earnings and revenue history

Current Revenue
$65.4M
Current Earnings
-$33.0M
Current Profit Margin
-50.4%

NPCE Return on Equity

Current Company
-153.8%
Current Industry
10.5%
Current Market
188%
NPCE's Return on Equity (-153.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when NPCE announces earnings.

NPCE Return on Assets

Current Company
-31.7%
Current Industry
5.3%
NPCE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NPCE Return on Capital Employed

Current Company
-26.73%
Current Industry
8.3%
NPCE has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NPCE vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NPCE$65.42M-$22.83M-$32.96M+15.33%N/A
MXCT$41.29M-$33.36M-$37.92M+17.55%N/A
ANIK$166.66M-$71.19M-$82.67M+9.56%N/A
SRDX$138.20M$22.74M$5.52M+9.81%-5.06%
PACB$200.52M-$277.28M-$306.74M+20.59%N/A
View Top Medical Device Stocks

NPCE earnings dates

Next earnings date
May 2, 2024

Neuropace Earnings & Revenue FAQ

What were NPCE's earnings last quarter?

On Invalid Date, Neuropace (NASDAQ: NPCE) reported Q4 2023 earnings per share (EPS) of -$0.22, up 50% year over year. Total Neuropace earnings for the quarter were -$6.20 million. In the same quarter last year, Neuropace's earnings per share (EPS) was -$0.44.

If you're new to stock investing, here's how to buy Neuropace stock.

What was NPCE's earnings growth in the past year?

As of Q2 2024, Neuropace's earnings has grown year over year. Neuropace's earnings in the past year totalled -$32.96 million.

What is NPCE's earnings date?

Neuropace's earnings date is Invalid Date. Add NPCE to your watchlist to be reminded of NPCE's next earnings announcement.

What was NPCE's revenue last quarter?

On Invalid Date, Neuropace (NASDAQ: NPCE) reported Q4 2023 revenue of $18.01 million up 40.84% year over year. In the same quarter last year, Neuropace's revenue was $12.79 million.

What was NPCE's revenue growth in the past year?

As of Q2 2024, Neuropace's revenue has grown 43.72% year over year. This is 34.39 percentage points higher than the US Medical Devices industry revenue growth rate of 9.32%. Neuropace's revenue in the past year totalled $65.42 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.